Summary
- Current Price
- As of today, COAG price is $51.74, up +3.75% on
- Current Price All-Time High
- COAG price is currently -3.49% below its historical high of $53.61 set on
- Market Cap
- COAG current market cap is $2B
- Revenue
- COAG current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for COAG is on
Profile
| Metric | Value |
|---|---|
| Full Name | Hemab Therapeutics Holdings, Inc. |
| Ticker | NASDAQ: COAG |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | hemab.com |
| Employees | 59 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $51.74 | |
| Price, 1D Change | +3.75% | |
| $2B | ||
| - | ||
| - | ||
| 1.24 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$31.82 | ||
| EPS, 1Y Change | -31.22% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | N/A | |
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$31.82 | ||
| EPS Estimate | -$3.06 | N/A |
| EPS Est. Change | +90.37% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $51.74 | |
| Price Target | $50.00 | - |
| Price Tgt. Change | -3.36% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$24.25 | - | |
| - | -$31.82 | - | |
| -$3.06 | N/A | +90.37% | |
| -$2.51 | N/A | +92.10% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $51.74 | |
| $34.40 | ||
| $37.35 | ||
| - | ||
| $39.59 | ||
| $3.58 | ||
| 1.24 | ||
| $4.02 | ||
| 63.63 | ||
| 76.34% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$31.82 | ||
| -$304.00K | ||
| - | ||
| -$70.12M | ||
| - | ||
| -$63.91M | ||
| - | ||
| -$69.82M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -2.05 | ||
| 18.03 | ||
| 18.03 | ||
| - | ||
| - | ||
| 2.53 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| -12.17 | ||
| -111.06 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$176.64M | ||
| $185.49M | ||
| $194.78M | ||
| $192.55M | ||
| $371.42M | ||
| $10.68M | ||
| $361.43M | ||
| $693.00K | ||
| $5.73M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $63.91M | ||
| $69.82M | ||
| $304.00K | ||
| $10.49M | ||
| $304.00K | ||
| $0.00 | ||
| -$227.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$61.48M | ||
| -$81.48M | ||
| $156.30M | ||
| $16.00K | ||
| -$61.49M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| Jefferies | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | ||
| Wedbush | ||
| Jefferies | ||
| Goldman Sachs | ||
| Evercore ISI Group |
Analyst sentiment
Institutional ownership
Screeners with COAG
FAQ
- What is the ticker symbol for Hemab Therapeutics Holdings, Inc.?
- The ticker symbol for Hemab Therapeutics Holdings, Inc. is NASDAQ:COAG
- Does Hemab Therapeutics Holdings, Inc. pay dividends?
- No, Hemab Therapeutics Holdings, Inc. does not pay dividends
- What sector is Hemab Therapeutics Holdings, Inc. in?
- Hemab Therapeutics Holdings, Inc. is in the Healthcare sector
- What industry is Hemab Therapeutics Holdings, Inc. in?
- Hemab Therapeutics Holdings, Inc. is in the Biotechnology industry
- What country is Hemab Therapeutics Holdings, Inc. based in?
- Hemab Therapeutics Holdings, Inc. is headquartered in United States
- When did Hemab Therapeutics Holdings, Inc. go public?
- Hemab Therapeutics Holdings, Inc. initial public offering (IPO) was on May 1, 2026
- Is Hemab Therapeutics Holdings, Inc. in the S&P 500?
- No, Hemab Therapeutics Holdings, Inc. is not included in the S&P 500 index
- Is Hemab Therapeutics Holdings, Inc. in the NASDAQ 100?
- No, Hemab Therapeutics Holdings, Inc. is not included in the NASDAQ 100 index
- Is Hemab Therapeutics Holdings, Inc. in the Dow Jones?
- No, Hemab Therapeutics Holdings, Inc. is not included in the Dow Jones index
- When does Hemab Therapeutics Holdings, Inc. report earnings?
- The next expected earnings date for Hemab Therapeutics Holdings, Inc. is August 14, 2026
Data Sources & References
- COAG Official Website www.hemab.com
- COAG Profile on Yahoo Finance finance.yahoo.com/quote/COAG
- COAG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/coag